Volume 14 Supplement 1
Abstracts of the 33rd Annual Meeting of the European Malignant Hyperthermia Group (EMHG)
Meeting abstracts
Edited by Frank Schuster, Stephan Johannsen and Norbert Roewer
The publication of this supplement has been funded by the University Hospital of Würzburg, Department of Anesthesia and Critical Care, Würzburg, Germany. The Supplement Editors declare that they have no competing interests.
Image credit: Frank Schuster/ Department of Anesthesia and Critical Care, University of Würzburg, Germany
33rd Annual Meeting of the European Malignant Hyperthermia Group (EMHG). Go to conference site.
Würzburg, Germany15-17 May 2014
-
Citation: BMC Anesthesiology 2014 14(Suppl 1):A1
-
Malignant hyperthermia testing in probands with NO adverse anesthetic reaction
Citation: BMC Anesthesiology 2014 14(Suppl 1):A2 -
Abstract withdrawn: 33rd Annual Meeting of the European Malignant Hyperthermia Group (EMHG)
Citation: BMC Anesthesiology 2014 14(Suppl 1):A3 -
Analysis of malignant hyperthermia results in Padua and Siena
Citation: BMC Anesthesiology 2014 14(Suppl 1):A4 -
Update of the quality assurance (QA) results of halothane and caffeine analysis of all current participating malignant hyperthermia units
Citation: BMC Anesthesiology 2014 14(Suppl 1):A5 -
A case of prolonged exertional rhabdomyolysis in a MHS individual
Citation: BMC Anesthesiology 2014 14(Suppl 1):A6 -
Dantrolene in the treatment of malignant hyperthermia: a case report
Citation: BMC Anesthesiology 2014 14(Suppl 1):A7 -
Intraoperative tachycardia, hypercapnia, hyperthermia and muscle stiffness in a dantrolene unavailability case. Can calcium channel blockers be valuable?
Citation: BMC Anesthesiology 2014 14(Suppl 1):A8 -
Carnitine palmitoyltransferase 2 deficiency, malignant hyperthermia and anesthesia
Citation: BMC Anesthesiology 2014 14(Suppl 1):A9 -
Malignant hyperthermia as a rare cause of SIRS after cardiac surgery
Citation: BMC Anesthesiology 2014 14(Suppl 1):A10 -
Malignant hyperthermia on ICU – sudden attack of the “snake”
Citation: BMC Anesthesiology 2014 14(Suppl 1):A11 -
Update of the EMHG database on genetic variants in type 1 ryanodine receptor and their possible impact on phenotype
Citation: BMC Anesthesiology 2014 14(Suppl 1):A12 -
Advantage from massive parallel sequencing of RYR1 and CACNA1S in diagnostics of malignant hyperthermia susceptibility
Citation: BMC Anesthesiology 2014 14(Suppl 1):A13 -
The introduction of a targeted next generation sequencing diagnostic service for MH
Citation: BMC Anesthesiology 2014 14(Suppl 1):A14 -
Targeted exon capture and NGS to investigate an undefined myopathy reveal RYR1 variants
Citation: BMC Anesthesiology 2014 14(Suppl 1):A15 -
Preferential allele amplification leading to RyR1 misgenotyping in a malignant hyperthermia susceptible individual
Citation: BMC Anesthesiology 2014 14(Suppl 1):A16 -
RYR1 mutation screening 1992 – 2014: a genetic report on 22 years from the Würzburg MH unit
Citation: BMC Anesthesiology 2014 14(Suppl 1):A17 -
Knowledge on malignant hyperthermia: as rare as the disease? A nation wide survey
Citation: BMC Anesthesiology 2014 14(Suppl 1):A18 -
Role of sarcoplasmic reticulum junctional proteins in skeletal muscle strength
Citation: BMC Anesthesiology 2014 14(Suppl 1):A19 -
Gene expression in the context of malignant hyperthermia status and ageing
Citation: BMC Anesthesiology 2014 14(Suppl 1):A20 -
Caenorhabditis elegans as a model organism for RYR1 variants and muscle ageing
Citation: BMC Anesthesiology 2014 14(Suppl 1):A21 -
Chronic use of low dose simvastatin does not alter the IVCT in normal rats
Citation: BMC Anesthesiology 2014 14(Suppl 1):A22 -
Accuracy of the diagnosis of malignant hyperthermia in hospital discharge records
Citation: BMC Anesthesiology 2014 14(Suppl 1):A23 -
MH in Russia: obstacle races
Citation: BMC Anesthesiology 2014 14(Suppl 1):A24 -
Development and evolution of the MHAUS cognitive aid for malignant hyperthermia
Citation: BMC Anesthesiology 2014 14(Suppl 1):A25 -
French guidelines for the management of malignant hyperthermia
Citation: BMC Anesthesiology 2014 14(Suppl 1):A26 -
Malignant hyperthermia and beyond - a virtual BioBank
Citation: BMC Anesthesiology 2014 14(Suppl 1):P1 -
100 telephone conversations about malignant hyperthermia
Citation: BMC Anesthesiology 2014 14(Suppl 1):P2
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 2.3
5-year Journal Impact Factor: 2.6
Source Normalized Impact per Paper (SNIP): 1.011
SCImago Journal Rank (SJR): 0.658
Speed 2024
Submission to first editorial decision (median days): 20
Submission to acceptance (median days): 130
Usage 2024
Downloads: 2,298,029
Altmetric mentions: 577
Peer-review Terminology
-
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication